A phase Iib openlabel randomized controlled trial to evaluate the efficacy & safety of Ivermectin in reducing viral loads in patients with hematological disorders who are admitted with Covid-19 infection (Ice study)

Acces sibility Controls

Christian Medical College

Principal Investigator

Dr. B. George Head & Professor Christian Medical College Tamil Nadu

Department of Science and Technology (DST)

Area of Research

Medical Sciences

Focus Area

Science & Engineering Research Board - Covid-19 (SERB-COVID)

Start Year

2020

End Year

2021

Sanction Amount

₹ 20.90 L

Status

Completed

No. of Research Paper

Technologies (If Any)

No. of PhD Produced

N/A

Startup (If Any)

No. of Patents

Filed :00

Grant :00

Acces sibility Controls